Avelumab, for Metastatic Merkel Cell Carcinoma | Observed Responses are Durable

Paul Nghiem, MD, PhD, University of Washington, explains Avelumab, for Metastatic Merkel Cell Carcinoma | Observed Responses are Durable at Annual Meeting 2018